Corvus Pharmaceuticals, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Corvus Pharmaceuticals, Inc. (CRVS) is 806.53M

According to Corvus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 806.53M. This represents a change of -16.25% compared to the average of 963.06M of the last 4 quarters.

Corvus Pharmaceuticals, Inc. (CRVS) Historical Enterprise Value (quarterly & annually)

How has CRVS Enterprise Value performed in the past?

The mean historical Enterprise Value of Corvus Pharmaceuticals, Inc. over the last ten years is 150.91M. The current 806.53M Enterprise Value has changed 434.44% with respect to the historical average. Over the past ten years (40 quarters), CRVS's Enterprise Value was at its highest in in the June 2026 quarter at 1.36B. The Enterprise Value was at its lowest in in the December 2018 quarter at -7260510.00.

Corvus Pharmaceuticals, Inc. (CRVS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corvus Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corvus Pharmaceuticals, Inc. (CRVS) Average Enterprise Value

How has CRVS Enterprise Value performed in the past?

The current Enterprise Value of Corvus Pharmaceuticals, Inc. (CRVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corvus Pharmaceuticals, Inc. (CRVS) Enterprise Value vs. Peers

How is CRVS’s Enterprise Value compared to its peers?

Corvus Pharmaceuticals, Inc.’s Enterprise Value is greater than Coherus Oncology, Inc. (78.32M), less than Arcus Biosciences, Inc. (2.25B), greater than Innate Pharma S.A. (130.19M), less than Nektar Therapeutics (1.19B), greater than CytomX Therapeutics, Inc. (470.78M), greater than Compugen Ltd. (178.88M), greater than NextCure, Inc. (15.48M), greater than MacroGenics, Inc. (75.66M), greater than Compass Therapeutics, Inc. (112.16M), greater than Adagene Inc. (-35230957.00),

Build a custom stock screener for Corvus Pharmaceuticals, Inc. (CRVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corvus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corvus Pharmaceuticals, Inc. (CRVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corvus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.